Skip to Main Content

Author Details

Jaime Bosch
University Clinic for Visceral Surgery and Medicine, Bern University
1971
600
118
PMIDPaper TitleJournal TitlePublished Year
37782566Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis.Hepatology2024
37852414Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding.J Hepatol2024
36058365Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis.J Hepatol2023
374822225-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial.J Hepatol2023
37841641Mechanobiology of portal hypertension.JHEP Rep2023
37222256Predictors and management of post-banding ulcer bleeding in cirrhosis: A systematic review and meta-analysis.Liver Int2023
37151732Increased sinusoidal pressure impairs liver endothelial mechanosensing, uncovering novel biomarkers of portal hypertension.JHEP Rep2023
37284139Pre-emptive TIPS for the treatment of bleeding from gastric fundal varices: Results of a randomised controlled trial.JHEP Rep2023
37183551Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode.Liver Int2023
36480715Letter: PCSK9 inhibitor for liver transplant patients during the post-statin era? Authors' reply.Aliment Pharmacol Ther2023
36750244Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis.Gut2023
36811400Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis.Hepatology2023
36908849Emerging Therapeutic Targets for Portal Hypertension.Curr Hepatol Rep2023
36897269Quantifying the benefit of nonselective beta-blockers in the prevention of hepatic decompensation: A Bayesian reanalysis of the PREDESCI trial.Hepatology2023
36064098Carvedilol as Best β-Blocker for Secondary Prophylaxis of Variceal Bleeding: Are We There, or Not Yet?Clin Gastroenterol Hepatol2023
36328772Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding.Gut2023
34662449Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis.Hepatology2022
35431106Corrigendum to 'Baveno VII - Renewing consensus in portal hypertension' [J Hepatol (2022) 959-974].J Hepatol2022
35862782Donor Simvastatin Treatment Is Safe and Might Improve Outcomes After Liver Transplantation: A Randomized Clinical Trial.Transplantation2022
36271472Letter: what explains improved survival from statin exposure after liver transplantation? Authors' reply.Aliment Pharmacol Ther2022
36063968Non-invasive tests for clinically significant portal hypertension after HCV cure.J Hepatol2022
35979872Use of statins after liver transplantation is associated with improved survival: results of a nationwide study.Aliment Pharmacol Ther2022
33716139FIB-4 Improves LSM-Based Prediction of Complications in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease.Clin Gastroenterol Hepatol2022
35194091Protein and miRNA profile of circulating extracellular vesicles in patients with primary sclerosing cholangitis.Sci Rep2022
32987029Small diameter shunts should lead to safe expansion of the use of TIPS.J Hepatol2021
33905794Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis.J Hepatol2021
33845059Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis.J Hepatol2021
33802486Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain.J Clin Med2021
34712934Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis.JHEP Rep2021
34072510Transcriptomic Profiling of the Liver Sinusoidal Endothelium during Cirrhosis Reveals Stage-Specific Secretory Signature.Cancers (Basel)2021
34039492Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction.J Hepatol2021
33982942Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.Am J Gastroenterol2021
34333790A Machine Learning Approach to Liver Histological Evaluation Predicts Clinically Significant Portal Hypertension in NASH Cirrhosis.Hepatology2021
34333101Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors.J Hepatol2021
34332438Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.J Autoimmun2021
34280344Web Exclusive. Annals for Hospitalists Inpatient Notes - Clinical Pearls-Hepatorenal Syndrome.Ann Intern Med2021
33314543Royal Free Hospital-estimated glomerular filtration rate for prognostic stratification of first acute kidney injury in cirrhosis.Liver Int2021
33278455Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease.J Hepatol2021
30649272Ischemia/Reperfusion Injury in the Aged Liver: The Importance of the Sinusoidal Endothelium in Developing Therapeutic Strategies for the Elderly.J Gerontol A Biol Sci Med Sci2020
31960441A Prognostic Strategy Based on Stage of Cirrhosis and HVPG to Improve Risk Stratification After Variceal Bleeding.Hepatology2020
32605877Corrigendum to: "Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury" [J Hepatol (2019) 458-469].J Hepatol2020
32690379Reply to: "Pre-emptive TIPS for acute variceal bleeding in acute-on-chronic liver failure: Is there enough evidence for a routine recommendation?": pTIPS for variceal bleeding in ACLF patients: when and why?J Hepatol2020
32939447Nuclear deformation mediates liver cell mechanosensing in cirrhosis.JHEP Rep2020
32996708Human amniotic stem cells improve hepatic microvascular dysfunction and portal hypertension in cirrhotic rats.Liver Int2020
32852811Letter: improve survival! Place early pre-emptive TIPSS in high-risk variceal bleeders.Aliment Pharmacol Ther2020
32736898Effect of poorly absorbable antibiotics on hepatic venous pressure gradient in cirrhosis: A systematic review and meta-analysis.Dig Liver Dis2020
32872239Oxidative Stress in Chronic Liver Disease and Portal Hypertension: Potential of DHA as Nutraceutical.Nutrients2020
32588789Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.United European Gastroenterol J2020
32923831Characterization and Proteome of Circulating Extracellular Vesicles as Potential Biomarkers for NASH.Hepatol Commun2020
32339602Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS.J Hepatol2020
  • 1 - 50 of 600

Recommended Authors

Thoetchai Peeraphatdit
University of Nebraska Medical Center
Career Start Year 2014
Number of shared co-authors 1
Neil Rajoriya
Queen Elizabeth Hospital Birmingham
Career Start Year 2009
Number of shared co-authors 0
Christopher Koh
Clinical Research Section
Career Start Year 2008
Number of shared co-authors 2
Andrew Scanga
Vanderbilt University Medical Center
Career Start Year 2003
Number of shared co-authors 0
Gideon M Hirschfield
University of Toronto
Career Start Year 2001
Number of shared co-authors 4
Byung Seok Kim
Catholic University of Daegu School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Won Young Tak
Kyungpook National University
Career Start Year 2001
Number of shared co-authors 3
Ali Al-Khafaji
University of Pittsburgh
Career Start Year 2001
Number of shared co-authors 0
Curtis K Argo
University of Virginia
Career Start Year 2000
Number of shared co-authors 0
Richard Gilroy
Intermountain Medical Center
Career Start Year 2000
Number of shared co-authors 1
Ali Zarrinpar
College of Medicine, University of Florida
Career Start Year 1999
Number of shared co-authors 0
Jayant A Talwalkar
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 0
Mitra K Nadim
Keck School of Medicine, University of Southern California
Career Start Year 1999
Number of shared co-authors 0
Steven-Huy B Han
David Geffen School of Medicine , University of California los angeles
Career Start Year 1997
Number of shared co-authors 3
Fedja A Rochling
University of Nebraska Medical Center
Career Start Year 1997
Number of shared co-authors 0
Peter St??rkel
Cliniques Universitaires Saint-Luc (CUSL)
Career Start Year 1996
Number of shared co-authors 6
Theo Heller
National Institute of Diabetes and Digestive and Kidney Diseases
Career Start Year 1996
Number of shared co-authors 2
Martin K Schilling
University Hospital of Homburg/Saar (DE)
Career Start Year 1990
Number of shared co-authors 0
David J Kramer
University of Wisconsin School of Medicine and Public Health in Madison
Career Start Year 1990
Number of shared co-authors 0
Christine M Hunt
Duke University Medical Center and Durham Veterans Affairs Health Care System
Career Start Year 1990
Number of shared co-authors 0
Grace L Su
University of Washington
Career Start Year 1989
Number of shared co-authors 1
Yoshiyuki Takei
Mie University
Career Start Year 1988
Number of shared co-authors 6
Pierre-Fran??ois Laterre
Centre Hospitalier Regional Mons-Hainaut
Career Start Year 1986
Number of shared co-authors 1
Hartmut Hecker
Hannover Medical School
Career Start Year 1982
Number of shared co-authors 1
Michael K Porayko
Vanderbilt University Medical Center
Career Start Year 1981
Number of shared co-authors 2
Michael Kutner
Emory University
Career Start Year 1976
Number of shared co-authors 0
Michael J Zinner
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1974
Number of shared co-authors 0
Marek Krawczyk
Medical University of Warsaw
Career Start Year 1969
Number of shared co-authors 0
Frank B Cerra
IRCCS Centro Neurolesi Messina
Career Start Year 1967
Number of shared co-authors 0
Rayford Scott Jones
University of Virginia, Surgical Outcomes Research Center
Career Start Year 1961
Number of shared co-authors 0

Collaborators

Arun J Sanyal
Virginia Commonwealth University
Co-authored papers 9
Stephen A Harrison
Pinnacle Clinical Research Center
Co-authored papers 8
Luis Ib????ez
Gregorio Maranon University Hospital
Co-authored papers 8
Zachary Goodman
Center for Liver Diseases, Inova Fairfax Hospital
Co-authored papers 8
Gopinath M Subramanian
John Hunter Children's Hospital
Co-authored papers 4
Genís Campreciós
Co-authored papers 3
Ariel E Feldstein
University of California San Diego
Co-authored papers 2
Davide Povero
Mayo Clinic
Co-authored papers 2
Wenhua Ren
University of Colorado Denver
Co-authored papers 2
George V Mazariegos
Co-authored papers 2
Akiko Eguchi
Mie University Graduate School of Medicine
Co-authored papers 2
Robert H Squires
University of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh
Co-authored papers 2
Ann E Thompson
University of Pittsburgh Medical Center
Co-authored papers 1
Patrick J McKiernan
Children's Hospital of Pittsburgh
Co-authored papers 1
Elias Campo
Institute for Biomedical Research August Pi I Sunyer
Co-authored papers 1
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 1
Rohit Loomba
Co-authored papers 1
Frank Tacke
Charite-Universitatsmedizin Berlin
Co-authored papers 1
Gianluca Trifirò
Co-authored papers 1
Lucila Ohno-Machado
Co-authored papers 1
Josep M Mercader
Co-authored papers 1
Robert Myers
Co-authored papers 1
Michael P Curry
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 1
Lucila Ohno-Machado
Escola de Administracao de Empresas - FGV, Stanford University, University of California San Diego, University of Sao Paulo, Yale School of Medicine
Co-authored papers 1
Jihoon Kim
university of california san diego
Co-authored papers 1
Masahiko Tameda
Mie University Graduate School of Medicine
Co-authored papers 1
Release 1.2